tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

RenovoRx Receives Nasdaq Notice for Bid Price Noncompliance

Story Highlights
  • RenovoRx received a Nasdaq deficiency notice on December 31, 2025.
  • The company has until June 30, 2026, and possibly longer, to restore its share price or face delisting risks.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
RenovoRx Receives Nasdaq Notice for Bid Price Noncompliance

Claim 70% Off TipRanks Premium

The latest announcement is out from RenovoRx ( (RNXT) ).

On December 31, 2025, RenovoRx, Inc. received a deficiency notice from Nasdaq stating that the company’s common stock had failed to meet the minimum $1.00 bid price requirement for continued listing on the Nasdaq Capital Market for 32 consecutive business days, although the notice did not immediately affect the stock’s listing status. The company has been granted an initial 180-day period, until June 30, 2026, to regain compliance by maintaining a closing bid price of at least $1.00 for ten consecutive business days, with the possibility of an additional 180-day extension if it meets other listing standards and commits to corrective actions such as a potential reverse stock split; failure to comply after these periods could lead to delisting proceedings, though the company would have the right to appeal.

The most recent analyst rating on (RNXT) stock is a Hold with a $0.80 price target. To see the full list of analyst forecasts on RenovoRx stock, see the RNXT Stock Forecast page.

Spark’s Take on RNXT Stock

According to Spark, TipRanks’ AI Analyst, RNXT is a Neutral.

The score is held down primarily by weak financial performance driven by sizable losses and sustained cash burn, reinforced by a bearish technical setup below major moving averages. Offsetting this somewhat, the latest earnings call was constructive with improving commercial traction and steady clinical-trial progress, while valuation support remains limited due to negative earnings and no dividend.

To see Spark’s full report on RNXT stock, click here.

More about RenovoRx

RenovoRx, Inc. is a publicly traded company listed on the Nasdaq Capital Market, with its primary business conducted through its common stock, which trades under Nasdaq’s listing and bid-price requirements.

Average Trading Volume: 373,082

Technical Sentiment Signal: Sell

Current Market Cap: $30.79M

See more data about RNXT stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1